ReviewFrontiers in endocrinology2026
Muscle-brain crosstalk in sarcopenia and cognitive impairment: endocrine signaling, metabolic regulation, and exercise modulation.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging is accompanied by progressive changes in endocrine signaling, metabolic regulation, and inter-organ communication that may contribute to functional decline. Sarcopenia and cognitive impairment frequently coexist in older adults, raising the possibility that their association involves disruption of communication between skeletal muscle and the brain in addition to shared age-related processes. This narrative review synthesizes clinical and mechanistic evidence on muscle-brain crosstalk in sarcopenia and cognitive impairment, with emphasis on endocrine and metabolic mechanisms and their modulation by exercise. Clinical evidence consistently links sarcopenia with cognitive impairment, while muscle strength and physical performance appear more closely related to cognitive function than muscle mass alone. Potential mechanisms include myokine and exerkine signaling, inflammaging and immune-endocrine dysregulation, mitochondrial dysfunction and oxidative stress, insulin resistance and glucose dysregulation, and lactate-mediated metabolic signaling. Exercise provides a dynamic physiological context in which several components of muscle-brain communication can be modified, including inflammatory, metabolic, neurotrophic, and lactate-related responses. However, direct evidence establishing complete signaling pathways in humans remains limited. Future studies integrating muscle and cognitive phenotypes with circulating biomarkers, metabolic measures, and neuroimaging are needed to clarify the clinical relevance of muscle-brain crosstalk in individuals with coexisting sarcopenia and cognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.